Straumann Holding AG Total Long-Term Assets 2012-2024 | SAUHY

Straumann Holding AG total long-term assets from 2012 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Straumann Holding AG total long-term assets for the quarter ending December 31, 2024 were $2.751B, a 183.31% increase year-over-year.
  • Straumann Holding AG total long-term assets for 2024 were $2.381B, a 10.67% increase from 2023.
  • Straumann Holding AG total long-term assets for 2023 were $2.152B, a 15.34% increase from 2022.
  • Straumann Holding AG total long-term assets for 2022 were $1.865B, a 18.46% increase from 2021.
Straumann Holding AG Annual Total Long-Term Assets
(Millions of US $)
2024 $2,381
2023 $2,152
2022 $1,865
2021 $1,575
2020 $1,489
2019 $1,518
2018 $1,124
2017 $1,010
2016 $642
2015 $521
2014 $545
2013 $494
2012 $486
2011 $289
Straumann Holding AG Quarterly Total Long-Term Assets
(Millions of US $)
2024-12-31 $2,751
2023-12-31 $2,463
2022-12-31 $2,110
2021-12-31 $1,772
2021-06-30 $971
2020-12-31 $1,648
2020-06-30 $738
2019-12-31 $1,624
2018-12-31 $1,470
2017-12-31 $1,332
2017-06-30 $551
2016-12-31 $521
2016-06-30 $503
2015-12-31 $805
2014-12-31 $827
2013-12-31 $404
2013-06-30 $373
2012-12-31 $486
2012-06-30 $418
2011-12-31 $164
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.704B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65